FR2979241B1 - Utilisation de compositions a faible teneur en polyamines dans la prevention ou le traitement des effets indesirables lies a un traitement anti-cancereux - Google Patents

Utilisation de compositions a faible teneur en polyamines dans la prevention ou le traitement des effets indesirables lies a un traitement anti-cancereux

Info

Publication number
FR2979241B1
FR2979241B1 FR1157646A FR1157646A FR2979241B1 FR 2979241 B1 FR2979241 B1 FR 2979241B1 FR 1157646 A FR1157646 A FR 1157646A FR 1157646 A FR1157646 A FR 1157646A FR 2979241 B1 FR2979241 B1 FR 2979241B1
Authority
FR
France
Prior art keywords
treatment
prevention
low
adverse effects
effects related
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1157646A
Other languages
English (en)
Other versions
FR2979241A1 (fr
Inventor
Bernard Cipolla
Xavier Artignan
Inventeur A Renonce A Etre Designe Un
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NUTRIALYS MEDICAL NUTRITION SA
Original Assignee
NUTRIALYS MEDICAL NUTRITION SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1157646A priority Critical patent/FR2979241B1/fr
Application filed by NUTRIALYS MEDICAL NUTRITION SA filed Critical NUTRIALYS MEDICAL NUTRITION SA
Priority to PCT/FR2012/051959 priority patent/WO2013030512A1/fr
Priority to EP12762342.9A priority patent/EP2750710A1/fr
Priority to JP2014527721A priority patent/JP2014529620A/ja
Priority to US14/241,694 priority patent/US20140294799A1/en
Priority to CA2847001A priority patent/CA2847001A1/fr
Publication of FR2979241A1 publication Critical patent/FR2979241A1/fr
Application granted granted Critical
Publication of FR2979241B1 publication Critical patent/FR2979241B1/fr
Priority to US15/099,070 priority patent/US20160228389A1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/127—Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/51—Lyases (4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR1157646A 2011-08-30 2011-08-30 Utilisation de compositions a faible teneur en polyamines dans la prevention ou le traitement des effets indesirables lies a un traitement anti-cancereux Expired - Fee Related FR2979241B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR1157646A FR2979241B1 (fr) 2011-08-30 2011-08-30 Utilisation de compositions a faible teneur en polyamines dans la prevention ou le traitement des effets indesirables lies a un traitement anti-cancereux
EP12762342.9A EP2750710A1 (fr) 2011-08-30 2012-08-30 Utilisation de compositions a faible teneur en polyamines dans la prevention ou le traitement des effets indesirables lies a un traitement anti-cancereux
JP2014527721A JP2014529620A (ja) 2011-08-30 2012-08-30 抗癌治療にリンクする副作用の予防または治療において低ポリアミン含有量を用いる組成物の使用
US14/241,694 US20140294799A1 (en) 2011-08-30 2012-08-30 Use of compositions having a low polyamine content in the prevention or treatment of adverse effects linked to cancer treatment
PCT/FR2012/051959 WO2013030512A1 (fr) 2011-08-30 2012-08-30 Utilisation de compositions a faible teneur en polyamines dans la prevention ou le traitement des effets indesirables lies a un traitement anti-cancereux
CA2847001A CA2847001A1 (fr) 2011-08-30 2012-08-30 Utilisation de compositions a faible teneur en polyamines dans la prevention ou le traitement des effets indesirables lies a un traitement anti-cancereux
US15/099,070 US20160228389A1 (en) 2011-08-30 2016-04-14 Use of compositions with a low polyamine content in the prevention or treatment of undesirable effects linked to an anti-cancer treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1157646A FR2979241B1 (fr) 2011-08-30 2011-08-30 Utilisation de compositions a faible teneur en polyamines dans la prevention ou le traitement des effets indesirables lies a un traitement anti-cancereux

Publications (2)

Publication Number Publication Date
FR2979241A1 FR2979241A1 (fr) 2013-03-01
FR2979241B1 true FR2979241B1 (fr) 2014-05-09

Family

ID=46889341

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1157646A Expired - Fee Related FR2979241B1 (fr) 2011-08-30 2011-08-30 Utilisation de compositions a faible teneur en polyamines dans la prevention ou le traitement des effets indesirables lies a un traitement anti-cancereux

Country Status (6)

Country Link
US (2) US20140294799A1 (fr)
EP (1) EP2750710A1 (fr)
JP (1) JP2014529620A (fr)
CA (1) CA2847001A1 (fr)
FR (1) FR2979241B1 (fr)
WO (1) WO2013030512A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL4009641T3 (pl) * 2011-09-09 2024-02-26 Lg Electronics Inc. Sposób dekodowania obrazu, sposób kodowania obrazu, sposób przesyłania danych dla informacji obrazu, odczytywalny komputerowo nośnik przechowujący strumień bitów obejmujący zakodowane informacje obrazu
WO2021095599A1 (fr) * 2019-11-13 2021-05-20 国立大学法人京都大学 Polythérapie comprenant un inhibiteur du signal de pd-1

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2706255B1 (fr) 1993-06-17 1995-10-27 Univ Rennes Composition à usage alimentaire et/ou pharmaceutique pauvre en polyamines et applications thérapeutiques.
US7425579B2 (en) 1998-04-21 2008-09-16 Universite Laval Methods for inhibiting activity of polyamine transporters
US20020099008A1 (en) 1999-04-26 2002-07-25 Daniel R. Twardzik Method for stimulating hematopoiesis using tgf-alpha
US6498192B1 (en) * 1999-08-30 2002-12-24 The University Of Tennessee Research Corporation Prevention of apoptosis in non-cancerous cells
WO2003013245A1 (fr) * 2001-08-07 2003-02-20 Wisconsin Alumni Research Foundation Polyamines et analogues assurant une protection des cellules a l'occasion des chimiotherapies et radiotherapies anticancereuses
US7727974B2 (en) 2001-08-10 2010-06-01 Eisai R & D Management Co., Ltd. Methods of reducing the severity of mucositis
US6841578B2 (en) 2001-08-16 2005-01-11 Stephen T. Sonis Treatment and prevention of mucositis in cancer patients
US20060275370A1 (en) * 2002-07-25 2006-12-07 Yih-Lin Chung Method and compositions for treatment of epithelial damage
FR2858231B1 (fr) 2003-07-31 2006-02-10 Univ Rennes Utilisation nouvelle d'une composition alimentaire a usage humain pauvre en polyamines pour la realisation d'un aliment therapeutique
ES2677868T3 (es) * 2003-10-16 2018-08-07 Nestec S.A. Composición nutricional frente a los efectos secundarios de la quimioterapia o de la radioterapia
JP2007537158A (ja) * 2004-02-13 2007-12-20 メディクエスト セラピューティックス インク アンチザイムフレームシフトを活性化するポリアミン類似体
ES2351665T3 (es) 2005-03-24 2011-02-09 Rottapharm S.P.A. Derivados de benzamidina para el tratamiento y la prevención de mucositis.
WO2006122162A2 (fr) 2005-05-10 2006-11-16 The University Of Chicago Procede et composition pour traiter la mucosite
EP1882473A1 (fr) 2006-07-28 2008-01-30 Indena S.P.A. Utilistation d'anthocyanosides pour la préparation de formulations pour le traitement de la mucosite induite par les médicaments antitumoraux
GB0704718D0 (en) 2007-03-12 2007-04-18 Prendergast Patrick T Compounds and methods for preventing and treating mucositis
WO2010148390A2 (fr) 2009-06-19 2010-12-23 University Of Central Florida Research Foundation, Inc. Inhibiteurs du transport de la polyamine en tant que nouvelle thérapeutique
WO2011016111A1 (fr) 2009-08-04 2011-02-10 トヨタ自動車株式会社 Dispositif et système de fourniture d’informations
WO2011031210A1 (fr) 2009-09-08 2011-03-17 Delaval Holding Ab Dispositif et procede servant a determiner la position des trayons d'un animal a traire
IT1396935B1 (it) 2009-11-26 2012-12-20 Solartium Entpr Ltd Uso di una combinazione per il trattamento delle mucositi indotte da radiazioni o da chemioterapici

Also Published As

Publication number Publication date
CA2847001A1 (fr) 2013-03-07
FR2979241A1 (fr) 2013-03-01
US20160228389A1 (en) 2016-08-11
WO2013030512A1 (fr) 2013-03-07
JP2014529620A (ja) 2014-11-13
US20140294799A1 (en) 2014-10-02
EP2750710A1 (fr) 2014-07-09

Similar Documents

Publication Publication Date Title
EP2751248A4 (fr) Compositions solides et liquides de traitement de textile
DK3040336T3 (da) Forbindelser til brug i behandling af TYK2 Kinase-medierede tilstande
FR2997302B1 (fr) Prevention et traitement des deficits en pyruvate deshydrogenase
BR112014009636A2 (pt) composição dietética destinada à prevenção do risco cardiometabólico
EP2888396A4 (fr) Utilisation d'une eau de traitement dans des applications de nettoyage
GB201316224D0 (en) Improvements in or relating to stairlifts
EP2862575A4 (fr) Application de picéatannol-3'-o-b-d-glucopyranoside dans la préparation de médicaments pour l'amélioration du blocage de la microcirculation
FR3000491B1 (fr) Composes utilisables dans le traitement des infections mycobacteriennes
GB201300139D0 (en) Improvements in or relating to concrete flooring
Haslam et al. IN SEARGH OF Charisma
FR2979241B1 (fr) Utilisation de compositions a faible teneur en polyamines dans la prevention ou le traitement des effets indesirables lies a un traitement anti-cancereux
GB2500584B (en) Improvements in or relating to log inversion
GB201106543D0 (en) Improvements in or relating to pump installations
GB2503514B (en) Improvements in or relating to the riding of horses
GB2510810B (en) Improvements in or relating to stairlifts
GB201211746D0 (en) Improvements in or relating to exercise devices
GB201200790D0 (en) Improvements in or relating to staircases
FR2987267B1 (fr) Application du modafinil dans le traitement de substitution des cacainomanes
LT2863932T (lt) Kompozicija, skirta naudoti limfedemos gydymui
GB2508793B (en) Improvements in or relating to hardware
GB2503199B (en) Improvements in or relating to stairlifts
GB2505191B (en) Improvements in or relating to retaining components in surfaces
GB2499408B (en) Improvements in or relating to stairlifts
FR2952823B1 (fr) Utilisation de la ferroquine dans le traitement ou la prevention du paludisme
GB201316055D0 (en) Improvements in or relating to clutches

Legal Events

Date Code Title Description
GC Lien (pledge) constituted

Effective date: 20130524

PLFP Fee payment

Year of fee payment: 6

ST Notification of lapse

Effective date: 20180430